Triple Combination Chemotherapy Effective For Advanced Colorectal Cancer, Trial Finds
Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval
Liver Transplants Extend Survival In Early-Stage Cancer
Trimodality Therapy Improves Survival In Early Disease
NCI Encourages IP Chemo For Stage III Ovarian Cancer
Study Finds No Evidence That Statins Cut Cancer Risk
Chest X-Ray Produces Many False-Positive Results
NMP22 Assay More Effective Than Conventional Lab Test
Chemotherapy After Surgery Extends Survival By 32%
Some Tumors Show Partial Response To Drug Combo
Recombinant TSH Avoids Need To Stop Replacement Therapy
Partial Responses To Zactima In Thyroid Cancer Trial
NCI-Approved Clinical Trials
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- A new working group will conduct site visits and advise NCAB and NCI director on cancer center grants
- Hoping to hit a $200M target, NCI and FNIH develop a plan for advancing cancer vaccines
NCI Director Letai: “How aggressive can we be?” - CBER Director Vinay Prasad dared to “say no to drugs”
- Letai: “From this point forward, it really is much more like business as usual at the NCI.”
- Early-onset colorectal cancer demands a new research playbook
